A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

A randomized placebo‐controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis

Published:2022-01-05 Issue: Volume: Page:
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle and Nerve

Author:

Cudkowicz Merit E.¹^ORCID,Lindborg Stacy R.²^ORCID,Goyal Namita A.³,Miller Robert G.⁴,Burford Matthew J.⁵,Berry James D.¹,Nicholson Katharine A.¹,Mozaffar Tahseen³^ORCID,Katz Jonathan S.⁴,Jenkins Liberty J.⁴,Baloh Robert H.⁵,Lewis Richard A.⁵^ORCID,Staff Nathan P.⁶,Owegi Margaret A.⁷,Berry Donald A.⁸,Gothelf Yael⁹,Levy Yossef S.¹⁰,Aricha Revital²,Kern Ralph Z.²,Windebank Anthony J.⁶,Brown Robert H.⁷^ORCID

Affiliation:

1. Healey Center, Mass General Hospital Harvard Medical School Boston MA USA

2. Research and Development Brainstorm Cell Therapeutics New York NY USA

3. UCI Health ALS & Neuromuscular Center University of California Irvine CA USA

4. Sutter Pacific Medical Foundation California Pacific Medical Center San Francisco CA USA

5. Department of Neurology Cedars‐Sinai Medical Center Los Angeles CA USA

6. Department of Neurology Mayo Clinic College of Medicine Rochester MN USA

7. Neurology Department University of Massachusetts Medical School Boston MA USA

8. Berry Consultants Houston TX USA

9. Research and Development Brainstorm Cell Therapeutics Petah Tikva Israel

10. Manufacturing Brainstorm Cell Therapeutics Petah Tikva Israel

Funder